|
|
|
|
| LEADER |
00000csc a2200000 a 4500 |
| 001 |
26612-3 |
| 005 |
20230308214906.0 |
| 008 |
001090|2000 ||||||||r|||||||||||spa|| |
| 020 |
|
|
|a 8348603524
|
| 040 |
|
|
|b spa
|
| 041 |
1 |
|
|a spa
|
| 082 |
0 |
|
|a 616.8
|
| 245 |
|
|
|a Toxicología clínica neuroconductual
|c James W. Albers y Stanley Berent editores; Carlos Escamilla traductor
|h imp
|n 3/4
|
| 264 |
|
|
|a Madrid
|b McGraw-Hill Interamericana
|c 2000
|
| 300 |
|
|
|a XII, pp 571-823
|b ilu
|
| 300 |
|
|
|c 22x16 cm
|
| 310 |
|
|
|a Trimestral
|
| 490 |
|
|
|a Clínicas Neurológicas de Norteamérica
|v volumen 3/4
|
| 504 |
|
|
|a incl. ref.
|
| 650 |
1 |
|
|a Neurotoxinas
|9 300504
|
| 650 |
1 |
|
|a Neurologia
|
| 650 |
|
|
|a Estructuras celulares
|9 300505
|
| 650 |
|
|
|a Neurotóxicos
|9 300506
|
| 650 |
|
|
|a Neurotoxicología clínica
|9 300507
|
| 650 |
|
|
|a Medición de la conducta
|9 300508
|
| 650 |
|
|
|a Neuroimagen
|9 275568
|
| 650 |
|
|
|a Trastornos neurotóxicos
|9 300509
|
| 650 |
|
|
|a Estado de ánimo
|9 300510
|
| 650 |
|
|
|a Afectividad
|9 7178
|
| 650 |
|
|
|a Gánglios basales
|9 300511
|
| 700 |
1 |
|
|a Albers, James W
|e editor
|9 300512
|
| 700 |
|
|
|a Berent, Stanley
|e editor
|9 300513
|
| 700 |
|
|
|a Escamilla, Carlos
|e traductor
|9 300514
|
| 773 |
|
|
|t Toxicología clínica neuroconductual
|
| 852 |
|
|
|a UC-SALUD
|c ESTANTERIA ABIERTA
|f Compra
|k teresa.bermeoh
|l 1
|m General
|p 20010903/20130624
|q S/. 1
|t 26612-3
|b 0
|d CDRS
|e CDRS
|g 616.8 ESTANTERIA ABIERTA
|z 2001-10-90
|
| 942 |
|
|
|
| 999 |
|
|
|c 129317
|d 129317
|